Clene (CLNN) Interest Coverage Ratio (2020 - 2026)
Clene (CLNN) posted Interest Coverage Ratio of 7.69 for Q2 2026, up 23.48% on a QoQ basis from 10.05 in Q4 2025, and up 11.46% year-over-year from 6.9 in Q2 2025.
Powered by 
Analysis
Clene (CLNN) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Clene has reported Interest Coverage Ratio for 7 years, with the latest figure at 7.69 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 11.46% year-over-year to 7.69 in Q2 2026; TTM through Jun 2026 was 8.81, a 6.0% increase from a year earlier, with the FY2025 full-year figure at 8.61, down 5.75% from the prior year.
- Interest Coverage Ratio was 7.69 for Q2 2026 at Clene, up from 10.05 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 5.77 in Q2 2024, with the low at 18.11 in Q2 2022.
- Average Interest Coverage Ratio over 5 years is 10.28, with a median of 8.7 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 96.59% in 2022, then slumped 102.86% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 12.88 in 2022, then soared by 35.77% to 8.28 in 2023, then plunged by 102.86% to 16.79 in 2024, then surged by 40.11% to 10.05 in 2025, then climbed by 23.48% to 7.69 in 2026.
- The last three Interest Coverage Ratio figures came in at 7.69 (Q2 2026), 10.05 (Q4 2025), and 8.7 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -21.24 |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 114.07 |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | -7.69 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.69 |
| Dec 31, 2025 | -10.05 |
| Sep 30, 2025 | -8.70 |
| Jun 30, 2025 | -8.69 |
| Mar 31, 2025 | -6.74 |
| Dec 31, 2024 | -16.79 |
| Sep 30, 2024 | -7.65 |
| Jun 30, 2024 | -5.77 |
| Mar 31, 2024 | -7.42 |
| Dec 31, 2023 | -8.28 |
| Sep 30, 2023 | -8.03 |
| Jun 30, 2023 | -9.36 |
| Mar 31, 2023 | -10.07 |
| Dec 31, 2022 | -12.88 |
| Sep 30, 2022 | -11.44 |
| Jun 30, 2022 | -18.11 |
| Mar 31, 2022 | -17.05 |
| Jun 30, 2021 | -530.77 |
| Mar 31, 2021 | -21.23 |
| Jun 30, 2020 | -24.01 |